Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Bristol-Myers Squibb Co    BMY

Delayed Quote. Delayed  - 05/27 10:00:56 pm
71.31 USD   +0.82%
05/23DJSAMSUNG ELECTRO : Targets U.S. Drug Market With Remicade Knockoff
05/23 BRISTOL MYERS S : to Hold Investor Teleconference to Discuss ASCO Hi..
05/20 INOVALON : Announces Agreement with Bristol-Myers Squibb to Focus on..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
05/23/2016 05/24/2016 05/25/2016 05/26/2016 05/27/2016 Date
70.4(c) 71.23(c) 70.69(c) 70.73(c) 71.31(c) Last
5 905 283 3 878 782 5 815 797 3 994 957 3 612 127 Volume
-0.52% +1.18% -0.76% +0.06% +0.82% Change
More quotes
Financials ($)
Sales 2016 18 539 M
EBIT 2016 4 854 M
Net income 2016 4 066 M
Debt 2016 802 M
Yield 2016 2,17%
Sales 2017 20 766 M
EBIT 2017 6 264 M
Net income 2017 5 139 M
Finance 2017 1 144 M
Yield 2017 2,31%
P/E ratio 2016 28,84
P/E ratio 2017 23,28
EV / Sales 2016 6,46x
EV / Sales 2017 5,68x
Capitalization 119 038 M
More Financials
Company
Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical products.Its pharmaceutical products include chemically-synthesized drugs or small molecules and an increasing portion of products produced from... 
Sector
Pharmaceuticals
Calendar
06/05 | 01:00amPresentation
More about the company
Surperformance© ratings of Bristol-Myers Squibb Co
Trading Rating : Investor Rating :
More Ratings
Latest news on BRISTOL-MYERS SQUIBB CO
05/23DJSAMSUNG ELECTRONICS : Targets U.S. Drug Market With Remicade Knockoff
05/23 BRISTOL MYERS SQUIBB : to Hold Investor Teleconference to Discuss ASCO Highlight..
05/20 INOVALON : Announces Agreement with Bristol-Myers Squibb to Focus on Real World ..
05/19 BRISTOL MYERS SQUIBB : and AbbVie Announce European Commission Approval of Empli..
05/19 BRISTOL MYERS SQUIBB : Trademark Application for "REAL-WORLD DATA ACROPOLIS" Fil..
05/19DJMERCK : New Hope for Melanoma Patients -- Update
05/18 BRISTOL MYERS SQUIBB : Two-Year Overall Survival Data from Two Pivotal Opdivo® (..
05/18DJMERCK : New Hope for Melanoma Patients
05/18 BRISTOL MYERS SQUIBB : FDA OKs immunotherapy drugs for bladder, blood cancers
05/18 BRISTOL MYERS SQUIBB : Breadth and Depth of Bristol-Myers Squibb’s Immuno-..
More news
Sector news : Pharmaceuticals - NEC
05/28 SUN PHARMACEUTICAL : Pharma Q4 profit seen up 113%, Gleevec may drive US sales
05/28 TAKEDA PHARMACEUTICAL : Receives Positive CHMP Opinion for ADCETRIS (brentuximab..
05/28DJSUBSCRIBERS : Covestro News Reported in April
05/28DJCovestro Eyes Acquisitions, Says Finance Chief - Report
05/28 ASTRAZENECA : S faslodex met primary endpoint in first-line treatment of advance..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
05/26 Whether We Want It Or Not, We All Need A Break
05/25 Achillion's Pipeline Strengthens, With Near-Term Potential Catalysts
05/25 INSIDERINSIGHTS.COM DAILY ROUND UP 5 : Shak, jgv
05/24 New commercial chief at ARIAD Pharma
05/22 GENERATION PORTFOLIO : Wish List
Advertisement
Chart BRISTOL-MYERS SQUIBB CO
Duration : Period :
Bristol-Myers Squibb Co Technical Analysis Chart | BMY | US1101221083 | 4-Traders
Full-screen chart
Technical analysis trends BRISTOL-MYERS SQU...
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions